Cowen Backs Outperforming Xilinx Stock

XLNX shares are holding right near record highs

by Josh Selway

Published on Apr 10, 2019 at 10:02 AM

Xilinx, Inc. (NASDAQ:XLNX) has been a notable outperformer in recent months, outpacing the S&P 500 Index (SPX) by almost 28 percentage points over the past 60 sessions. In fact, Schaeffer's Quantitative Analyst Chris Prybal just pointed out that XLNX has seen the largest increase in market cap since September among all companies valued under $40 billion, up $12.9 billion in that time. Analysts at Cowen have taken notice, this morning raising their outlook on the stock.

The brokerage firm raised its price target to $130 from $105, expecting the company to benefit from increasing investments in 5G infrastructure through the end of 2019. This was part of the firm's broader view that the semiconductor sector should improve in the second half of 2019, though it still recommends a stock-picking strategy for the space. At last check, Xilinx stock was trading at $129.10, right below its record high of $130.65 from a week ago.

For Advanced Micro Devices, Inc. (NASDSAQ:AMD), Cowen raised its price target by $5 to $33, saying the company is in a good position to compete with rival Intel (INTC). AMD shares were last seen trading up 1.5% at $27.68. The equity has been in a trend of higher highs and lows in 2019, and hasn't traded below the 20-day moving average since March 18.

In the options pits, near-term traders are almost evenly split between puts and calls. That's according to the security's Schaeffer's put/call open interest ratio (SOIR) of 0.99, showing an equal amount of put and call open interest among contracts expiring within three months.

From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Race for Pot Profits Is On
The race for marijuana profits is on... and one up-and-comer is taking the "Buffett" approach to profits.
2 Stocks Sinking on Healthcare Sector Uncertainty
Both names are seeing heavier-than-usual options activity
Bear Note Pushes Cronos Group Stock Lower
BofA-Merrill Lynch just initiated coverage with an "underperform" rating
The Race for Pot Profits Is On
The race for marijuana profits is on... and one up-and-comer is taking the "Buffett" approach to profits.